G-quadruplexes: a promising target for cancer therapy | Molecular Cancer | Full Text
Dexamethasone induced inhibition of Dectin-1 activation of antigen presenting cells is mediated via STAT-3 and NF-κB signaling pathways | Scientific Reports
Annkristin HEINE | Medical Doctor | Professor | University of Bonn - Medical Center, Bonn | Haematology Oncology | Research profile
Medicine®
Unter der Leitung von Frau Prof.... - Krebszentrum CIO Bonn | Facebook
UKB NewsRoom | Erfolg bei Ausschreibung „Advanced Clinician Scientist“
Krebszentrum CIO Bonn - Ich bin Prof. Annkristin Heine | Facebook
Prof. Dr. med. Annkristin Heine - Hämatologie und Onkologie des Universitätsklinikums Bonn
Team | IMMEI
Transfection of Dendritic Cells with in Vitro-Transcribed CMV RNA Induces Polyclonal CD8+- and CD4+-Mediated CMV-Specific T Cell
Team | IMMEI
AG Heine - Hämatologie und Onkologie des Universitätsklinikums Bonn
CIO Bonn - Tumorboards
ONLINE Cluster Lecture Series
The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and Function | PLOS ONE
Frontiers | Red blood cell transfusions impact response rates to immunotherapy in patients with solid malignant tumors
Long-term survival correlates with immunological responses in renal cell carcinoma patients treated with mRNA-based immunotherap
Cardiac MRI in Suspected Acute COVID-19 Myocarditis
The PI3Kδ inhibitor idelalisib impairs the function of human dendritic cells | SpringerLink
Total marrow irradiation versus total body irradiation using intensity-modulated helical tomotherapy,Journal of Cancer Research and Clinical Oncology - X-MOL
Volume 21, Issue 3, Pages (October 2017) - ppt download
PDF) Long-term survival after vaccination with RNA coding for TAA in Renal Cell Carcinoma: update on survival and correlation with immunological response
Researchers release the brakes on the immune | EurekAlert!
Clinical and immunological effects of mRNA vaccines in malignant diseases | Molecular Cancer | Full Text
Ann-Kristin Müller – Stellvertretende Niederlassungsleiterin – Heine + Beisswenger Gruppe | LinkedIn
Pacritinib protects dendritic cells more efficiently than ruxolitinib - Experimental Hematology
UKB NewsRoom | Annkristin Heine
